Company Filing History:
Years Active: 2023
Title: David M Johnson: Innovator in Therapeutic Combinations
Introduction
David M Johnson is a notable inventor based in Aptos, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic combinations for treating various conditions.
Latest Patents
David M Johnson holds a patent for "Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JAK-2 inhibitor, and/or a BCL-2 inhibitor." This patent describes innovative combinations of inhibitors, including those selective for specific isoforms of phosphoinositide 3-kinase (PI3K), Janus kinase-2 (JAK-2), Bruton's tyrosine kinase (BTK), and B-cell lymphoma-2 (BCL-2). The invention provides therapeutic combinations that enhance treatment efficacy.
Career Highlights
David M Johnson is associated with Acerta Pharma B.V., where he has been instrumental in advancing research and development in the pharmaceutical sector. His work focuses on creating effective therapeutic strategies that leverage the potential of various inhibitors.
Collaborations
David has collaborated with notable colleagues, including Ahmed Hamdy and Wayne Philip Rothbaum. These collaborations have contributed to the innovative research and development efforts at Acerta Pharma B.V.
Conclusion
David M Johnson's contributions to the field of therapeutic combinations highlight his innovative spirit and dedication to improving healthcare solutions. His work continues to influence the pharmaceutical industry positively.